Clinical Trials Browser

Interventional × vistusertib × Gynecologic × Clear all

NCT02208375 2025-12-31

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Phase 1 Active not recruiting

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT02730923 2024-02-13

VICTORIA

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms